ImmunoScape Series B

• Round size vs peers

  Smaller than the typical Series B round.

• Syndicate size

  Healthy syndicate of 4 investors.

• Insider conviction

  All-new money, no prior investors re-upped.

• Investor track record

  Mostly newer or unproven managers.

Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.